Apr 25, 2023 by James HalleyWhy Shares of Arrowhead Pharmaceuticals Are Up TuesdayThe clinical-stage biotech announced promising news regarding a potential therapy for inflammatory pulmonary diseases.
Apr 25, 2023 by James Halley2 Monster Stocks to Buy Without Any HesitationThese stocks have grown revenue, earnings and share price over the past five years.
Apr 25, 2023 by James Halley3 Top Biotech Stocks Defying the Bear MarketAll three companies have therapies with strong sales potential.
Apr 24, 2023 by James HalleyWhy Shares of Bionano Genomics Are Up MondayThe life sciences company said it expects another improved quarter of revenue.
Apr 24, 2023 by James HalleyWhy Shares of Royal Philips Jumped MondayThe company's first-quarter earnings calmed some investors' concerns.
Apr 24, 2023 by James HalleyGE Healthcare Is Set to Ride the AI Trend. Here's Why That's Good for Investors.Machine learning is central to GE HealthCare's innovations.
Apr 22, 2023 by James Halley3 Top Dividend Kings to Buy for the Long HaulThese healthcare stocks all have above-average dividends.
Apr 21, 2023 by James HalleyWhy Shares of Invitae Soared on FridayArk Innovation CEO Cathie Wood said the stock is undervalued.
Apr 21, 2023 by James HalleyWhy Shares of Keros Therapeutics Jumped This WeekThe company appointed a new director and an analyst reiterated his position on the stock.
Apr 20, 2023 by James HalleyWhy Shares of Protagonist Therapeutics Rose This WeekThe company's lead pipeline candidate is making news.
Apr 20, 2023 by James HalleyWhy Shares of Roivant Sciences Jumped This WeekThe company's stock benefited from another company's buyout.
Apr 20, 2023 by James HalleyWhy Shares of Bellus Health Skyrocketed This WeekThe company has received a buyout offer from GSK.
Apr 20, 2023 by James HalleyWhy Shares of Geron Are Up 30% This WeekThe company's CEO was scheduled to speak at a virtual conference on Thursday.
Apr 19, 2023 by James HalleyWhy Shares of Legend Biotech Jumped WednesdayA leaked abstract on a phase 3 trial for the company's multiple myeloma drug Carvykti gave the stock a jolt.
Apr 18, 2023 by James Halley3 Robinhood Stocks to Buy and Hold ForeverThere are solid reasons for the trio's popularity with retail investors.
Apr 17, 2023 by James HalleyWhy Shares of Editas Medicine Rose MondayThe company is benefiting from positive news affecting other gene-editing stocks.
Apr 17, 2023 by James HalleyWhy Shares of Prometheus Biosciences Are Soaring MondayMerck's $10.8 billion buyout offer sent the clinical-stage biotech stock higher.
Apr 16, 2023 by James Halley3 Stocks You Can Keep ForeverThree solid profitable companies that are growing their businesses and their dividends.
Apr 15, 2023 by James HalleyDoes an FDA Fast Track Designation Make Regenxbio Stock a Buy Now?The company focuses on using its technology for gene-editing therapies.
Apr 14, 2023 by James HalleyWhy Shares of Brookdale Senior Living Rose This WeekThe company says it expects improved first-quarter numbers.
